Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Pernix Therapeutics Holdings, Inc.

NASDAQ: PTXHealthcare / Drug Manufacturers - Other / USA
1.14-0.4700-29.19%Vol 2 157 0081Y Perf -51.47%
Feb 15th, 2019 16:00
BID1.14 ASK1.25
Open1.60 Previous Close1.61
Pre-Market1.55 After-Trading1.17
 -0.06 -3.73%  0.03 2.63%
Target Price
3.00 
Analyst Rating
— 0.00
Potencial %
163.16 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★+     41.13
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)17 
Earnings Rating
Neutral
Price Range Ratio 52wk %
28.71 
Earnings Date
14th Mar 2019

Today's Price Range

1.131.60

 

52wk Range

0.27003.30

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
165.12%
3 Months
96.55%
6 Months
-24.00%
1 Year
-51.47%
3 Years
-94.60%
5 Years
-95.88%

Quotes

Name / TickerPriceChg.Chg.%
PTX1.14-0.4700-29.19
AAPL170.42-0.3800-0.22
GOOG1 113.65-8.0200-0.72
MSFT108.221.32001.23
XOM77.711.44001.89
WFC49.220.70001.44
JNJ136.382.07001.54
FB162.50-1.4500-0.88
GE10.090.05000.50
JPM105.553.13003.06
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.80
Current Ratio
1.10
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-3.50
Leverage Ratio -1.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
68.80
EBIT Margin
-16.00
EBITDA Margin
9.10
Pre-tax Profit Margin
-69.20
Profit Margin
-62.33
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
5.79
PS Ratios
0.14
Price to Cash Flow
35.40
Price to Free Cash Flow
-0.10
Cash Flow Per Share
-1.81
Price to Tangible Book
-0.03
Book Value per Share
-14.12
Enterprise Value (in ths.)
309 987
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-696.24
ROE last 12 Months
43.88
Return on Assets (5Y Avg)
-35.32
ROA last 12 Months
-29.58
Return on Capital (5Y Avg)
-
ROC last 12 Months
-
Return on invested Capital Q
-
Return on invested Capital Y
-
Assets Turnover
0.10
Receivables Turnover
0.70
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
85 748
Revenue per Share
5.91
Revenue Growth 3 Years
-16.35
Revenue Growth 5 Years
3.93
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q04 2017--2.78-
Q04 2016--3.86-
Q03 2016--2.73-
Q02 2016-0.50-4.90-880.00
Q01 20160.00-3.50-
Q04 2015-0.20-5.90-2 850.00
Q03 20150.100.80700.00
Q02 2015-0.10-1.00-900.00
Earnings Per EndEstimateRevision %Trend
12/2016 FY-3.700.00-
12/2017 FY0.100.00-
----
----
Next Report Date14th Mar 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume2 157 008
Shares Outstanding (in ths.)14 506
Trades Count2 838
Dollar Volume2 734 189
Avg. Volume922 663
Avg. Weekly Volume3 967 344
Avg. Monthly Volume1 361 966
Avg. Quarterly Volume981 087

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

83%17%

Bearish Bullish

78%22%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
1 (100.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Hold
3.00

There are no comments yet.

News